Patients with acute non-traumatic headaches. Other headache syndromes
Conditions
Interventions
Intervention 1: Intervention group 1 was treated with intravenous ketorolac at a dose of 0.5 mg / kg intravenously in a single dose. Intervention 2: Intervention group 2 received intravenous ketamine
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: All patients with complaints of non-traumatic acute headache patients with aged of 18 to 50 years old Patients with a variety of headaches including tension and cluster migraine headaches
Exclusion criteria
Exclusion criteria: Subjects who have contraindications to the use of ketorolac and vitamin drugs Patients with focal neurological disorder Pregnant and weaning women Patients with headache with impaired consciousness level Patients with Comorbidity Headaches (Liver and Kidney Failure and Immune Deficiency)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score of patients with acute non-traumatic headache with visual analogue scale. Timepoint: Pain will be measured immediately before drug administration, 30 minutes, 1 minute and 2 hours after drug administration. Method of measurement: Visual Analog Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contacthamid reza beyg rezaee
Kermanshah University of Medical Sciences
Outcome results
None listed